Lack of dopaminergic modulation of cognitive flexibility

Shawn Smyth, David Q. Beversdorf

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To evaluate performance on a cognitive flexibility task after administration of a dopaminergic agonist. BACKGROUND: L-3,4- dihydroxyphenylalanine, which is converted into dopamine and norepinephrine, results in a restriction of the semantic network in priming experiments. Recent evidence suggests that flexibility of access to semantic networks in problem solving is mediated by the noradrenergic system. We wished to determine if dopaminergic agonists also affect this type of cognitive flexibility. METHODS: Eighty-four subjects were tested twice on an anagram task, once 1 hour after bromocriptine (dopamine agonist) and once 1 hour after placebo administration. RESULTS: No difference was detected between placebo and bromocriptine on anagram performance. CONCLUSIONS: Therefore, modulation of this type of cognitive flexibility does not seem to be mediated by the dopaminergic system. This suggests that the noradrenergic modulation of cognitive flexibility previously reported does not seem to extend to the dopaminergic system among catecholamines.

Original languageEnglish (US)
Pages (from-to)225-229
Number of pages5
JournalCognitive and Behavioral Neurology
Volume20
Issue number4
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Dopamine Agonists
Bromocriptine
Semantics
Placebos
Levodopa
Catecholamines
Dopamine
Norepinephrine

Keywords

  • Catecholamine
  • Cognitive flexibility
  • Creativity
  • Dopaminergic
  • Noradrenergic
  • Problem solving
  • Semantic

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Cognitive Neuroscience
  • Psychiatry and Mental health

Cite this

Lack of dopaminergic modulation of cognitive flexibility. / Smyth, Shawn; Beversdorf, David Q.

In: Cognitive and Behavioral Neurology, Vol. 20, No. 4, 01.12.2007, p. 225-229.

Research output: Contribution to journalArticle

Smyth, Shawn ; Beversdorf, David Q. / Lack of dopaminergic modulation of cognitive flexibility. In: Cognitive and Behavioral Neurology. 2007 ; Vol. 20, No. 4. pp. 225-229.
@article{16caf93acfa241c99280a48b1a5b8c5a,
title = "Lack of dopaminergic modulation of cognitive flexibility",
abstract = "OBJECTIVE: To evaluate performance on a cognitive flexibility task after administration of a dopaminergic agonist. BACKGROUND: L-3,4- dihydroxyphenylalanine, which is converted into dopamine and norepinephrine, results in a restriction of the semantic network in priming experiments. Recent evidence suggests that flexibility of access to semantic networks in problem solving is mediated by the noradrenergic system. We wished to determine if dopaminergic agonists also affect this type of cognitive flexibility. METHODS: Eighty-four subjects were tested twice on an anagram task, once 1 hour after bromocriptine (dopamine agonist) and once 1 hour after placebo administration. RESULTS: No difference was detected between placebo and bromocriptine on anagram performance. CONCLUSIONS: Therefore, modulation of this type of cognitive flexibility does not seem to be mediated by the dopaminergic system. This suggests that the noradrenergic modulation of cognitive flexibility previously reported does not seem to extend to the dopaminergic system among catecholamines.",
keywords = "Catecholamine, Cognitive flexibility, Creativity, Dopaminergic, Noradrenergic, Problem solving, Semantic",
author = "Shawn Smyth and Beversdorf, {David Q.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1097/WNN.0b013e31815e6244",
language = "English (US)",
volume = "20",
pages = "225--229",
journal = "Cognitive and Behavioral Neurology",
issn = "1543-3633",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Lack of dopaminergic modulation of cognitive flexibility

AU - Smyth, Shawn

AU - Beversdorf, David Q.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - OBJECTIVE: To evaluate performance on a cognitive flexibility task after administration of a dopaminergic agonist. BACKGROUND: L-3,4- dihydroxyphenylalanine, which is converted into dopamine and norepinephrine, results in a restriction of the semantic network in priming experiments. Recent evidence suggests that flexibility of access to semantic networks in problem solving is mediated by the noradrenergic system. We wished to determine if dopaminergic agonists also affect this type of cognitive flexibility. METHODS: Eighty-four subjects were tested twice on an anagram task, once 1 hour after bromocriptine (dopamine agonist) and once 1 hour after placebo administration. RESULTS: No difference was detected between placebo and bromocriptine on anagram performance. CONCLUSIONS: Therefore, modulation of this type of cognitive flexibility does not seem to be mediated by the dopaminergic system. This suggests that the noradrenergic modulation of cognitive flexibility previously reported does not seem to extend to the dopaminergic system among catecholamines.

AB - OBJECTIVE: To evaluate performance on a cognitive flexibility task after administration of a dopaminergic agonist. BACKGROUND: L-3,4- dihydroxyphenylalanine, which is converted into dopamine and norepinephrine, results in a restriction of the semantic network in priming experiments. Recent evidence suggests that flexibility of access to semantic networks in problem solving is mediated by the noradrenergic system. We wished to determine if dopaminergic agonists also affect this type of cognitive flexibility. METHODS: Eighty-four subjects were tested twice on an anagram task, once 1 hour after bromocriptine (dopamine agonist) and once 1 hour after placebo administration. RESULTS: No difference was detected between placebo and bromocriptine on anagram performance. CONCLUSIONS: Therefore, modulation of this type of cognitive flexibility does not seem to be mediated by the dopaminergic system. This suggests that the noradrenergic modulation of cognitive flexibility previously reported does not seem to extend to the dopaminergic system among catecholamines.

KW - Catecholamine

KW - Cognitive flexibility

KW - Creativity

KW - Dopaminergic

KW - Noradrenergic

KW - Problem solving

KW - Semantic

UR - http://www.scopus.com/inward/record.url?scp=37349030077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349030077&partnerID=8YFLogxK

U2 - 10.1097/WNN.0b013e31815e6244

DO - 10.1097/WNN.0b013e31815e6244

M3 - Article

VL - 20

SP - 225

EP - 229

JO - Cognitive and Behavioral Neurology

JF - Cognitive and Behavioral Neurology

SN - 1543-3633

IS - 4

ER -